The European Commission’s work to secure access to potential COVID-19 vaccines is welcome, but other therapies are needed to end the pandemic and negotiations with European manufacturers of anti-viral antibodies should not be further delayed
Newly appointed to its governing board, former MEP Paul Rübig says the European Institute of Innovation and Technology will play a key role in reviving innovation value chains - from shuttered universities, to cash strapped SMEs, to market
Viewpoint: ‘responsible research and innovation’ policies in Horizon 2020 don’t often translate into action, a new study shows. A broader, deeper effort is needed
COVID-19 has elevated, but also exposed scientists. Politicians want clarity, but it’s crucial to explain what is known, unknown and unknowable, says Rolf-Dieter Heuer, chair of the EU group of chief scientific advisers
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.